Floatz logo

24 assets in Primary Progressive Multiple Sclerosis

Therapeutic assets addressing Primary Progressive Multiple Sclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Ocrelizumab
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P4BBB (76)
Rituximab
Primary Progressive Multiple Sclerosis
Rigshospitalet, DenmarkP3B (63)
Desloratadine
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (62)
Dexasone
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (62)
Fenebrutinib
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (60)
Fexofenadine
Primary Progressive Multiple Sclerosis
Rigshospitalet, DenmarkP3B (60)
Kyv-101
Primary Progressive Multiple Sclerosis
Kyverna TherapeuticsP2B (60)
Metformin
Primary Progressive Multiple Sclerosis
University Hospital, AntwerpP2B (60)
Orelabrutinib
Primary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLCP3B (60)
Diphenhydramine
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (58)
Acetylcysteine
Primary Progressive Multiple Sclerosis
Emmanuelle Waubant, MD PhDP2CCC (53)
Remibrutinib
Primary Progressive Multiple Sclerosis
Moein AminP2CCC (53)
Bendamustine
Primary Progressive Multiple Sclerosis
Tr1X, Inc.P1/2CC (47)
Clemastin
Primary Progressive Multiple Sclerosis
University of California, San FranciscoP1/2CC (47)
trx319
Primary Progressive Multiple Sclerosis
Tr1X, Inc.P1/2CC (47)
Pipe-791
Primary Progressive Multiple Sclerosis
Contineum TherapeuticsP1CC (46)
Cyclophosphamide
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P1CC (43)
Fludarabine
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P1CC (43)
hbi0101 cart
Primary Progressive Multiple Sclerosis
Polina StepenskyP1CC (43)
Idp-023
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P1CC (43)
Intranasal Foralumab
Primary Progressive Multiple Sclerosis
Tiziana Life Sciences LTDP1CC (43)
Mesna
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P1CC (43)
Orca-Q
Primary Progressive Multiple Sclerosis
Stanford UniversityP1CC (43)
s103 cells
Primary Progressive Multiple Sclerosis
Xijing HospitalP1CC (43)